David de Graaf, based in Boston, MA, US, is currently a Co-Founder, CEO and President at Reverb Therapeutics. David de Graaf brings experience from previous roles at NewCo, Ability Biologics and Inkling LLC. David de Graaf holds a 1995 - 1997 Weizmann Institute of Science. With a robust skill set that includes Systems Biology, Life Sciences, Biopharmaceuticals, Molecular Biology, Pharmaceuticals and more. David de Graaf has 3 emails and 3 mobile phone numbers on RocketReach.
Looking for a different David de Graaf?
Find contact details for 700 million professionals.